STERIS (STE) director Mohsen Sohi exercises 3,781 options, surrenders 1,837 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
STERIS plc director Mohsen Sohi reported a routine stock option exercise combined with a cashless settlement. On July 1, 2026, he exercised options to acquire 3,781 Ordinary Shares at $71.40 per share. As part of a net cashless stock option exercise, 1,837 shares were surrendered to the company, valued at $212.30 per share, to pay the option price rather than using cash. Following these transactions, Sohi directly held 26,142 Ordinary Shares of STERIS plc, indicating a modest net increase in his equity position from this option exercise.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,781 shares exercised/converted
Mixed
3 txns
Insider
Sohi Mohsen
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Director Stock Option (right to buy) | 3,781 | $0.00 | -- |
| Exercise | Ordinary Shares | 3,781 | $71.40 | $270K |
| Tax Withholding | Ordinary Shares | 1,837 | $212.30 | $390K |
Holdings After Transaction:
Director Stock Option (right to buy) — 0 shares (Direct, null);
Ordinary Shares — 26,142 shares (Direct, null)
Footnotes (1)
- Net - Cashless Stock Option Exercise - Options to purchase 1,837 shares were surrendered to the Company for payment of the option price. Options surrendered were valued based on the Company stock closing market price on the NYSE on the day on which the Net - Cashless Stock Option Exercise occurred. This option to purchase 3,781 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,781 ordinary shares for $71.40 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.
Key Figures
Options exercised: 3,781 shares
Option exercise price: $71.40 per share
Shares surrendered: 1,837 shares
+2 more
5 metrics
Options exercised
3,781 shares
Ordinary Shares acquired via option exercise (code M) on July 1, 2026
Option exercise price
$71.40 per share
Strike price of Director Stock Option exercised for 3,781 shares
Shares surrendered
1,837 shares
Shares surrendered to company in Net - Cashless Stock Option Exercise
Share value used for surrender
$212.30 per share
Closing NYSE market price used to value surrendered shares
Shares held after exercise
26,142 shares
Total Ordinary Shares directly owned after completing the transactions
Key Terms
Net - Cashless Stock Option Exercise, Director Stock Option (right to buy), derivative exercise/conversion, Ordinary Shares, +1 more
5 terms
Net - Cashless Stock Option Exercise financial
"Net - Cashless Stock Option Exercise - Options to purchase 1,837 shares were surrendered to the Company"
Director Stock Option (right to buy) financial
"security_title": "Director Stock Option (right to buy)""
derivative exercise/conversion financial
"transaction_action": "derivative exercise/conversion""
fully vested financial
"This option to purchase 3,781 STERIS plc ordinary shares, which is fully vested, was received"
FAQ
What insider transaction did STERIS (STE) director Mohsen Sohi report?
Mohsen Sohi reported exercising stock options for STERIS plc Ordinary Shares and settling the cost by surrendering some shares. He exercised 3,781 shares and surrendered 1,837 shares in a net cashless transaction, resulting in additional directly held shares.
Was Mohsen Sohi’s STERIS (STE) transaction an open-market sale or purchase?
The Form 4 shows no open-market buys or sells. It records an options exercise (code M) and a related share surrender (code F) to pay the option price, a tax/price-settlement mechanism rather than a discretionary market trade.
What was the origin of the 3,781 STERIS (STE) options Mohsen Sohi exercised?
Footnotes state this fully vested option to buy 3,781 STERIS plc Ordinary Shares at $71.40 per share was received in connection with STERIS’s redomiciliation to Ireland in March 2019, replacing an earlier Old STERIS stock option.